title: Serum alanine transaminase level is a good predictor of response to interferon alfa therapy for chronic hepatitis B in human immunodeficiency virus-infected patients.
authors.forename: V
authors.initials: V
authors.lastname: Di Martino
authors.forename: T
authors.initials: T
authors.lastname: Thevenot
authors.forename: N
authors.initials: N
authors.lastname: Boyer
authors.forename: F
authors.initials: F
authors.lastname: Degos
authors.forename: P
authors.initials: P
authors.lastname: Marcellin
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000150:complications*; D000410:Alanine Transaminase / Q000097:blood*; D019694:Hepatitis B, Chronic / Q000150:complications / Q000201:enzymology / Q000628:therapy*; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D016898:Interferon-alpha; D000410:Alanine Transaminase